Skip to main content
. 2014 Apr 10;9(4):e94495. doi: 10.1371/journal.pone.0094495

Figure 2. Prevalence of TDRM in patients diagnosed from 2002 through 2007.

Figure 2

Prevalence of TDRM is shown for any of the drug classes (any class), nucleoside reverse transcriptase inhibitor (NRTI), non-nucleoside reverse transcriptase inhibitor (NNRTI) and protease inhibitor (PI) in (A) Men having sex with men (MSM), and in (B) heterosexuals (HSX). The p-values of the time trends are shown on the right side of the graph.